Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients
To estimate protection from <i>cytomegalovirus</i> (CMV) replication after solid organ transplantation, CMV serology has been considered insufficient and thus CMV immunity is increasingly assessed by cellular in vitro methods. We compared two commercially available IFN-γ ELISpot assays (...
| Հիմնական հեղինակներ: | , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
MDPI AG
2021-01-01
|
| Շարք: | Vaccines |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://www.mdpi.com/2076-393X/9/2/88 |